Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: A population-based study

Renata Abrahão, Ruth H. Keogh, Daphne Y. Lichtensztajn, Rafael Marcos-Gragera, Bruno C. Medeiros, Michel P. Coleman, Raul C. Ribeiro, Theresa H Keegan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A better understanding of factors associated with early death and survival among children, adolescents and young adults with acute myeloid leukaemia (AML) may guide health policy aimed at improving outcomes in these patients. We examined trends in early death and survival among 3935 patients aged 0-39 years with de novo AML in California during 1988-2011 and investigated the associations between sociodemographic and selected clinical factors and outcomes. Early death declined from 9·7% in 1988-1995 to 7·1% in 2004-2011 (P = 0·062), and survival improved substantially over time. However, 5-year survival was still only 50% (95% confidence interval 47-53%) even in the most recent treatment period (2004-2011). Overall, the main factors associated with poor outcomes were older age at diagnosis, treatment at hospitals not affiliated with National Cancer Institute-designated cancer centres, and black race/ethnicity. For patients diagnosed during 1996-2011, survival was lower among those who lacked health insurance compared to those with public or private insurance. We conclude that mortality after AML remained strikingly high in California and increased with age. Possible strategies to improve outcomes include wider insurance coverage and treatment at specialized cancer centres.

Original languageEnglish (US)
Pages (from-to)292-302
Number of pages11
JournalBritish Journal of Haematology
Volume173
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Acute Myeloid Leukemia
Young Adult
Survival
Population
Insurance Coverage
National Cancer Institute (U.S.)
Health Insurance
Health Policy
Insurance
Neoplasms
Therapeutics
Confidence Intervals
Mortality

Keywords

  • Acute myeloid leukaemia
  • Early death
  • Population-based
  • Survival

ASJC Scopus subject areas

  • Hematology

Cite this

Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011 : A population-based study. / Abrahão, Renata; Keogh, Ruth H.; Lichtensztajn, Daphne Y.; Marcos-Gragera, Rafael; Medeiros, Bruno C.; Coleman, Michel P.; Ribeiro, Raul C.; Keegan, Theresa H.

In: British Journal of Haematology, Vol. 173, No. 2, 01.04.2016, p. 292-302.

Research output: Contribution to journalArticle

Abrahão, Renata ; Keogh, Ruth H. ; Lichtensztajn, Daphne Y. ; Marcos-Gragera, Rafael ; Medeiros, Bruno C. ; Coleman, Michel P. ; Ribeiro, Raul C. ; Keegan, Theresa H. / Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011 : A population-based study. In: British Journal of Haematology. 2016 ; Vol. 173, No. 2. pp. 292-302.
@article{9fb0388aa25a43c5ac9ccc8575076f8a,
title = "Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: A population-based study",
abstract = "A better understanding of factors associated with early death and survival among children, adolescents and young adults with acute myeloid leukaemia (AML) may guide health policy aimed at improving outcomes in these patients. We examined trends in early death and survival among 3935 patients aged 0-39 years with de novo AML in California during 1988-2011 and investigated the associations between sociodemographic and selected clinical factors and outcomes. Early death declined from 9·7{\%} in 1988-1995 to 7·1{\%} in 2004-2011 (P = 0·062), and survival improved substantially over time. However, 5-year survival was still only 50{\%} (95{\%} confidence interval 47-53{\%}) even in the most recent treatment period (2004-2011). Overall, the main factors associated with poor outcomes were older age at diagnosis, treatment at hospitals not affiliated with National Cancer Institute-designated cancer centres, and black race/ethnicity. For patients diagnosed during 1996-2011, survival was lower among those who lacked health insurance compared to those with public or private insurance. We conclude that mortality after AML remained strikingly high in California and increased with age. Possible strategies to improve outcomes include wider insurance coverage and treatment at specialized cancer centres.",
keywords = "Acute myeloid leukaemia, Early death, Population-based, Survival",
author = "Renata Abrah{\~a}o and Keogh, {Ruth H.} and Lichtensztajn, {Daphne Y.} and Rafael Marcos-Gragera and Medeiros, {Bruno C.} and Coleman, {Michel P.} and Ribeiro, {Raul C.} and Keegan, {Theresa H}",
year = "2016",
month = "4",
day = "1",
doi = "10.1111/bjh.13944",
language = "English (US)",
volume = "173",
pages = "292--302",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011

T2 - A population-based study

AU - Abrahão, Renata

AU - Keogh, Ruth H.

AU - Lichtensztajn, Daphne Y.

AU - Marcos-Gragera, Rafael

AU - Medeiros, Bruno C.

AU - Coleman, Michel P.

AU - Ribeiro, Raul C.

AU - Keegan, Theresa H

PY - 2016/4/1

Y1 - 2016/4/1

N2 - A better understanding of factors associated with early death and survival among children, adolescents and young adults with acute myeloid leukaemia (AML) may guide health policy aimed at improving outcomes in these patients. We examined trends in early death and survival among 3935 patients aged 0-39 years with de novo AML in California during 1988-2011 and investigated the associations between sociodemographic and selected clinical factors and outcomes. Early death declined from 9·7% in 1988-1995 to 7·1% in 2004-2011 (P = 0·062), and survival improved substantially over time. However, 5-year survival was still only 50% (95% confidence interval 47-53%) even in the most recent treatment period (2004-2011). Overall, the main factors associated with poor outcomes were older age at diagnosis, treatment at hospitals not affiliated with National Cancer Institute-designated cancer centres, and black race/ethnicity. For patients diagnosed during 1996-2011, survival was lower among those who lacked health insurance compared to those with public or private insurance. We conclude that mortality after AML remained strikingly high in California and increased with age. Possible strategies to improve outcomes include wider insurance coverage and treatment at specialized cancer centres.

AB - A better understanding of factors associated with early death and survival among children, adolescents and young adults with acute myeloid leukaemia (AML) may guide health policy aimed at improving outcomes in these patients. We examined trends in early death and survival among 3935 patients aged 0-39 years with de novo AML in California during 1988-2011 and investigated the associations between sociodemographic and selected clinical factors and outcomes. Early death declined from 9·7% in 1988-1995 to 7·1% in 2004-2011 (P = 0·062), and survival improved substantially over time. However, 5-year survival was still only 50% (95% confidence interval 47-53%) even in the most recent treatment period (2004-2011). Overall, the main factors associated with poor outcomes were older age at diagnosis, treatment at hospitals not affiliated with National Cancer Institute-designated cancer centres, and black race/ethnicity. For patients diagnosed during 1996-2011, survival was lower among those who lacked health insurance compared to those with public or private insurance. We conclude that mortality after AML remained strikingly high in California and increased with age. Possible strategies to improve outcomes include wider insurance coverage and treatment at specialized cancer centres.

KW - Acute myeloid leukaemia

KW - Early death

KW - Population-based

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84957669064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957669064&partnerID=8YFLogxK

U2 - 10.1111/bjh.13944

DO - 10.1111/bjh.13944

M3 - Article

C2 - 26847024

AN - SCOPUS:84957669064

VL - 173

SP - 292

EP - 302

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -